Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Completed
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Incyte BioSciences France
- Target Recruit Count
- 120
- Registration Number
- NCT04048564
- Locations
- 🇫🇷
CHU SUD Reunion GHSR, Saint-Pierre, Reunion, France
🇫🇷CHU Amiens-Picardie- Site SUD, Amiens Cedex, France
🇫🇷CHU D'Angers, Angers, France
News
No news found